Ignyta's IPO

Ignyta raised a round of funding on March 14, 2014. Investors include Public.

Ignyta, formerly NexDx, specializes in precision medicine and biotechnology, with an integrated Rx/Dx approach in oncology, for the benefit of cancer patients everywhere.…

Articles about Ignyta's IPO: